echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Alzheimer's vaccine may come out

    Alzheimer's vaccine may come out

    • Last Update: 2020-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The cause of the disease has been debated for many yearsIn recent years, many kinds of drugs based on amyloid hypothesis have been defeated in clinical trialsAD research began to turn to other hypotheses, among which tau protein hypothesis has attracted more and more attention from the field of AD drug research and development around the worldThe < br / > tau hypothesis suggests that ad is caused by the slow movement of brain cells related to tau proteinSpecifically, neurofibrillary tangles (NFT), a collection of saturated tau proteins, are important markers of Alzheimer's disease< br / > in a newly published study, researchers at the University of New Mexico (UNM) brought new hopeThe researchers detailed the development of a vaccineThe vaccine may not only prevent tau tangles, but also memory problems related to tau tangles, so that Alzheimer's can be "immunized"Relevant contents have been published in npj vaccines< br / > < br / > the vaccine was modified by virus like particles (VLP)Mice with the same symptoms as human Alzheimer's disease after gene editing were used as test objectsAfter vaccination, it was observed that the mice produced antibodies to eliminate tau protein, which could last for several months in the brain of miceMaphis and Kiran Bhaskar, associate professors of the Department of molecular genetics and microbiology of the UN m, also found that the mice vaccinated not only performed better in the maze test than those not vaccinated, but also showed less brain atrophy and less tangles in cortex and hippocampus in MRI scan, It's the areas of the brain that are damaged by Alzheimer's disease that are relieved< br / > < br / > although the vaccine has passed the mouse experiment and achieved success, it is not known when the human clinical trial can be carried outAt present, researchers are seeking sponsorship to commercialize vaccines for long-term development< br / > Maria CCarrillo, chief scientific officer of the Alzheimer's Association, praised the study, saying: "any science that offers hope for Alzheimer's and other dementia is a blessing for millions of people who face it today and in the future." < br / > reference materials: < br / > [1] researchers have long dreamed of an Alzheimer's vaccine Now it may finally be within reach
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.